Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert P Nelson

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Journal of Clinical Neuromuscular Disease|June 5, 2009
Rituximab for the treatment of thymoma-associated and de novo myasthenia gravis: 3 cases and reviewRobert P Nelson, Robert M Pascuzzi, Kenneth Kessler, et al.
Clinical Pharmacokinetics|May 11, 2011
Pharmacokinetics of subcutaneous IgPro20 in patients with primary immunodeficiencyRichard L Wasserman, Isaac Melamed, Robert P Nelson, et al.
Journal of Clinical Immunology|January 10, 2012
Immune-mediated diseases and immunodeficiencies associated with thymic epithelial neoplasmsMuhammad Rizwan Khawaja, Robert P Nelson, Nicholas Miller, et al.
Pharmacotherapy|November 20, 2019
Pharmacokinetics of Basiliximab for the Prevention of Graft-versus-Host Disease in Patients Undergoing Hematopoietic Cell Transplantation with Minimal-Intensity Cyclophosphamide and FludarabineJagdeep T Podichetty, Bryan J Brinda, Robert P Nelson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 7, 2012
Comparison of pulmonary complications after nonmyeloablative and conventional allogeneic hematopoietic cell transplantKhalil J Diab, Zhangsheng Yu, Karen L Wood, et al.
The Annals of Thoracic Surgery|March 17, 2012
Thymic carcinoma: outcomes after surgical resectionIkenna C Okereke, Kenneth A Kesler, Richard K Freeman, et al.
Plos One|August 23, 2012
Molecular analysis of thymomaSunil Badve, Chirayu Goswami, Yesim Gökmen-Polar, et al.
The Annals of Thoracic Surgery|March 27, 2010
Prognostic indicators after surgery for thymomaIkenna C Okereke, Kenneth A Kesler, Mohamed H Morad, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 23, 2010
A phase I trial of high-dose clofarabine, etoposide, and cyclophosphamide and autologous peripheral blood stem cell transplantation in patients with primary refractory and relapsed and refractory non-Hodgkin lymphomaShivani Srivastava, David Jones, Lisa L Wood, et al.
American Journal of Hematology|October 28, 2014
Cyclophosphamide/fludarabine nonmyeloablative allotransplant for acute myeloid leukemiaMuhammad Rizwan Khawaja, Susan M Perkins, Jennifer E Schwartz, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Journal of Clinical Neuromuscular Disease|June 5, 2009
Rituximab for the treatment of thymoma-associated and de novo myasthenia gravis: 3 cases and reviewRobert P Nelson, Robert M Pascuzzi, Kenneth Kessler, et al.
Clinical Pharmacokinetics|May 11, 2011
Pharmacokinetics of subcutaneous IgPro20 in patients with primary immunodeficiencyRichard L Wasserman, Isaac Melamed, Robert P Nelson, et al.
Journal of Clinical Immunology|January 10, 2012
Immune-mediated diseases and immunodeficiencies associated with thymic epithelial neoplasmsMuhammad Rizwan Khawaja, Robert P Nelson, Nicholas Miller, et al.
Pharmacotherapy|November 20, 2019
Pharmacokinetics of Basiliximab for the Prevention of Graft-versus-Host Disease in Patients Undergoing Hematopoietic Cell Transplantation with Minimal-Intensity Cyclophosphamide and FludarabineJagdeep T Podichetty, Bryan J Brinda, Robert P Nelson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 7, 2012
Comparison of pulmonary complications after nonmyeloablative and conventional allogeneic hematopoietic cell transplantKhalil J Diab, Zhangsheng Yu, Karen L Wood, et al.
The Annals of Thoracic Surgery|March 17, 2012
Thymic carcinoma: outcomes after surgical resectionIkenna C Okereke, Kenneth A Kesler, Richard K Freeman, et al.
Plos One|August 23, 2012
Molecular analysis of thymomaSunil Badve, Chirayu Goswami, Yesim Gökmen-Polar, et al.
The Annals of Thoracic Surgery|March 27, 2010
Prognostic indicators after surgery for thymomaIkenna C Okereke, Kenneth A Kesler, Mohamed H Morad, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 23, 2010
A phase I trial of high-dose clofarabine, etoposide, and cyclophosphamide and autologous peripheral blood stem cell transplantation in patients with primary refractory and relapsed and refractory non-Hodgkin lymphomaShivani Srivastava, David Jones, Lisa L Wood, et al.
American Journal of Hematology|October 28, 2014
Cyclophosphamide/fludarabine nonmyeloablative allotransplant for acute myeloid leukemiaMuhammad Rizwan Khawaja, Susan M Perkins, Jennifer E Schwartz, et al.
Pageof 4